SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN)
Clinical trials for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for head and neck cancer patients who failed chemo?
Disease control Not yet recruitingThis study tests whether adding an experimental drug (ficerafusp alfa) to a standard immunotherapy (nivolumab) can shrink tumors better than nivolumab alone in people with advanced head and neck cancer that stopped responding to platinum chemotherapy. About 131 adults whose cance…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN)
Phase: PHASE2 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated May 26, 2026 11:37 UTC
-
New program aims to speed up cancer care for ER patients
Knowledge-focused Not yet recruitingThis study tests a program where trained community health workers help head and neck cancer patients who first went to the emergency room. The goal is to see if this support can reduce delays in getting diagnosed and starting treatment. About 24 adults will take part, and their r…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: University of Tennessee • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC